b12 with semaglutide Semaglutide + Vit. B12 CAPS

Description

Oral GLP-1 removes the largest stated initiation barrier for 43% of obesity patients, expanding the treatment-seeking population by an estimated 60 to 90 million patients within three years

Mental health: Obesity is often associated with low self-esteem, depression, and anxiety due to societal stigma and body image concerns

Tens of millions are watching from the sidelines: wanting to lose weight, but unable to afford hefty price tags, concerned about side effects or simply unwilling to go the pharmaceutical route

[DOI] [PMC free article] [PubMed] [Google Scholar] 229.Plans, C

Another GLP-1 agonist, Tirzepatide /drugs/tirzepatide (Mounjaro), is currently approved only for treating type 2 diabetes /type-2-diabetes/guide/treatment/ but is expected to gain approval for use as a weight loss drug soon